SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
Anna Fagre, Juliette Lewis, Miles Eckley et al. · PLOS Pathogens · 2021
Abstract only
Infectious Diseases
Filters2 filters applied
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
Angela Choi, Matthew Koch, Kai Wu et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
Amadea Britton, Kara M. Jacobs Slifka, Chris Edens et al. · MMWR. Morbidity and Mortality Weekly Report · 2021
Full textCC BY
Persistence of Pathogens on Inanimate Surfaces: A Narrative Review
Jan Erik Wißmann, Lisa Kirchhoff, Yannick Brüggemann et al. · Microorganisms · 2021 · Review
Full textCC BY
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier et al. · The Lancet Respiratory Medicine · 2021 · Randomised trial
Abstract only
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido et al. · Frontiers in Immunology · 2021 · Review
Full textCC BY
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Obesity and COVID-19: what makes obese host so vulnerable?
Sameer Mohammad, Rafia Aziz, Saeed Al Mahri et al. · Immunity & Ageing · 2021 · Review
Abstract only
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
Victor M Corman, Verena Claudia Haage, Tobias Bleicker et al. · The Lancet Microbe · 2021
Abstract only
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
Savannah E. Butler, Andrew R. Crowley, Harini Natarajan et al. · Frontiers in Immunology · 2021
Full textCC BY
Efficient detection of SARS-CoV-2 RNA in the solid fraction of wastewater
Kouichi Kitamura, Kenji Sadamasu, Masamichi Muramatsu et al. · Science of The Total Environment · 2021
Abstract only
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Timothy Farinholt, Harsha Doddapaneni, Xiang Qin et al. · BMC Medicine · 2021
Full textCC BY
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Peter Bergman, Ola Blennow, Lotta Hansson et al. · eBioMedicine · 2021
Abstract only
COVID-19 vaccines
Duduzile Ndwandwe, Charles S Wiysonge · Current Opinion in Immunology · 2021 · Review
Abstract only
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu et al. · Infectious Diseases of Poverty · 2021 · Meta-analysis
Full textCC BY
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance
Xiantao Zhang, Shijian Wu, Bolin Wu et al. · Signal Transduction and Targeted Therapy · 2021
Full textCC BY
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann-Nagele, Thomas Koller et al. · Microbiology Spectrum · 2021
Full textCC BY
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M. Hastie, Haoyang Li, Daniel Bedinger et al. · Science · 2021
Full textCC BY
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Pieter L. A. Fraaij et al. · Nature Communications · 2021
Full textCC BY
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells
Jae Hyung Jung, Min-Seok Rha, Moa Sa et al. · Nature Communications · 2021
Full textCC BY